Yahoo
LSE - Delayed Quote GBp

NIOX Group Plc (NIOX.L)

66.97 -0.63 (-0.93%)
As of 10:47:36 AM GMT. Market Open.
Chart Range Bar
Loading chart for NIOX.L
  • Previous Close 67.60
  • Open 69.00
  • Bid 66.80 x --
  • Ask 67.60 x --
  • Day's Range 66.60 - 69.00
  • 52 Week Range 53.84 - 80.00
  • Volume 96,876
  • Avg. Volume 764,242
  • Market Cap (intraday) 271.382M
  • Beta (5Y Monthly) -0.09
  • PE Ratio (TTM) 33.48
  • EPS (TTM) 0.02
  • Earnings Date Sep 29, 2026
  • Forward Dividend & Yield 0.02 (2.29%)
  • Ex-Dividend Date May 21, 2026
  • 1y Target Est 82.40

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

www.niox.com

97

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

NIOX.L
0.88%
FTSE 100 (^FTSE)
8.10%

1-Year Return

NIOX.L
2.64%
FTSE 100 (^FTSE)
10.48%

3-Year Return

NIOX.L
0.01%
FTSE 100 (^FTSE)
44.17%

5-Year Return

NIOX.L
59.22%
FTSE 100 (^FTSE)
47.57%

Analyst Insights

View More

Analyst Price Targets

77.00
82.40 Average
66.97 Current
86.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.74%

  • Return on Assets (ttm)

    9.02%

  • Return on Equity (ttm)

    10.73%

  • Revenue (ttm)

    47.5M

  • Net Income Avi to Common (ttm)

    7M

  • Diluted EPS (ttm)

    0.02

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    16.8M

  • Total Debt/Equity (mrq)

    1.06%

  • Levered Free Cash Flow (ttm)

    8.2M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: